Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRME | AZN | AMGN | GILD | VRTX |
| Company | Prime Medicine Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.98 | 90.37 | 329.09 | 120.98 | 455.65 |
| High | 4.28 | 91.29 | 329.67 | 122.37 | 457.17 |
| Low | 3.83 | 89.67 | 320.77 | 120.59 | 439.80 |
| Latest | 4.20 | 91.32 | 321.32 | 121.32 | 442.02 |
| Change | +0.46 | +1.14 | -8.57 | +0.10 | -13.46 |
| % Change | +12.30% | +1.26% | -2.60% | +0.08% | -2.96% |
| Volume | 4,489,660 | 6,109,999 | 1,944,699 | 3,513,706 | 1,072,406 |
| 20-Day Average Volume | 4,036,572 | 5,532,536 | 2,842,024 | 6,860,125 | 1,396,839 |
| Previous Close | 3.74 | 90.18 | 329.89 | 121.22 | 455.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.67 | 90.16 | 337.56 | 124.46 | 434.64 |
| 20-Day Raw Stochastic | 98.62% | 64.93% | 7.71% | 33.68% | 60.05% |
| 20-Day Relative Strength | 51.25 | 61.52 | 49.49 | 47.80 | 56.28 |
| Weighted Alpha | +2.15 | +40.63 | +19.56 | +28.68 | -1.32 |
| Today's Opinion | 24% Buy | 100% Buy | 80% Buy | 80% Buy | 24% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 80% Buy | 80% Buy | 40% Buy |
| Last Month's Opinion | 40% Buy | 100% Buy | 56% Buy | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +21.29% since 12/01/25 | +0.70% since 12/01/25 | -4.71% since 12/01/25 | -2.66% since 12/01/25 | +3.98% since 12/01/25 |
| Low | 3.26 on 12/02/25 | 89.68 on 12/08/25 | 321.42 on 12/08/25 | 120.38 on 12/05/25 | 424.06 on 12/02/25 |
| High | 4.26 on 12/08/25 | 91.28 on 12/03/25 | 346.38 on 12/03/25 | 125.60 on 12/03/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | +11.42% since 11/07/25 | +7.77% since 11/07/25 | +0.44% since 11/07/25 | +1.84% since 11/07/25 | +8.08% since 11/07/25 |
| Low | 3.17 on 11/14/25 | 85.85 on 11/10/25 | 319.54 on 11/10/25 | 117.13 on 11/10/25 | 410.50 on 11/10/25 |
| High | 4.26 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +9.13% since 09/08/25 | +11.76% since 09/08/25 | +14.78% since 09/08/25 | +4.44% since 09/08/25 | +11.96% since 09/08/25 |
| Low | 3.17 on 11/14/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 6.94 on 10/06/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +151.18% since 06/06/25 | +25.07% since 06/06/25 | +10.77% since 06/06/25 | +7.62% since 06/06/25 | -1.77% since 06/06/25 |
| Low | 1.40 on 06/13/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 6.94 on 10/06/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 675,111 | 279,686,592 | 177,639,520 | 150,395,232 | 115,563,928 |
| Shares Outstanding, K | 180,511 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 2,980,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -195,880,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 1,230,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -50,580,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 2.69 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 11/07/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/11/25 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | 09/10/19 | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.70 | 15.55 | 14.97 | 29.87 |